Asia-Pacific Medical Gas Equipment Market Research Report – Segmented By Product (Medical Gases, Medical Gas Mixtures, Medical Gas Equipment), Application, End-users and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis From 2025 to 2033
The Asia-Pacific medical gas equipment market size was valued at USD 4.80 billion in 2024. The market is estimated at USD 5.25 billion in 2025. It is projected to reach USD 10.69 billion by 2033, at a CAGR of 9.3% during the forecast period from 2025 to 2033.
The Asia Pacific medical gas equipment market plays a critical role in ensuring the safe delivery and management of medical gases such as oxygen, nitrous oxide, and carbon dioxide, which are indispensable for modern healthcare systems. This market encompasses a wide range of equipment, including gas delivery systems, manifolds, vacuum systems, and monitoring devices, all designed to support patient care in hospitals, clinics, and ambulatory settings.
The escalating prevalence of respiratory disorders across the Asia Pacific serves as a significant driver for the medical gas equipment market. Chronic respiratory conditions, such as asthma and COPD, are becoming increasingly common, driven by urbanization, air pollution, and lifestyle factors. These conditions often necessitate prolonged oxygen therapy, creating a sustained demand for reliable medical gas systems. Urban centers like Beijing and Delhi, which frequently experience hazardous levels of air pollution, are particularly vulnerable. The WHO states that air quality in these cities often exceeds safe limits by up to five times, exacerbating respiratory ailments and increasing hospital admissions. This trend has compelled healthcare providers to invest in advanced medical gas equipment, such as centralized oxygen delivery systems, to manage the growing patient load efficiently. Furthermore, the rise in smoking rates, particularly in Southeast Asia, contributes to respiratory diseases.
The rapid expansion of healthcare infrastructure in the Asia Pacific, particularly in emerging economies, is another key driver of the medical gas equipment market. Countries like Vietnam and Indonesia are witnessing unprecedented growth in hospital construction and modernization projects. These expansions necessitate the installation of comprehensive medical gas systems to meet international standards of care. Also, government initiatives to improve rural healthcare access are driving demand. This infrastructure boom ensures that medical gas equipment manufacturers have a steady pipeline of opportunities to capitalize on.
One of the most significant restraints hindering the growth of the Asia Pacific medical gas equipment market is the high cost associated with installation and maintenance. Centralized medical gas systems, which include pipelines, manifolds, and monitoring devices, require substantial upfront investment. For small and medium-sized healthcare facilities, especially in rural areas, these costs can be prohibitive. Maintenance costs further compound the financial burden, as these systems require regular inspections and servicing to ensure compliance with safety standards. Skilled technicians are often needed to perform these tasks, but their availability is limited in many parts of the region. This shortage not only increases operational risks but also discourages smaller institutions from adopting advanced medical gas equipment, thereby limiting market penetration.
Stringent regulatory standards governing the design, installation, and operation of medical gas systems pose another significant challenge for the market. Compliance with international norms, such as those set by the International Organization for Standardization (ISO) and the National Fire Protection Association (NFPA), is mandatory for healthcare facilities. However, adhering to these regulations often requires costly modifications and rigorous testing, which can deter adoption, especially in resource-constrained settings. For example, ISO 7396-1 mandates specific performance criteria for medical gas pipeline systems, including pressure stability and leak prevention. Meeting these standards necessitates advanced engineering expertise, which is often lacking in developing nations. Furthermore, regional disparities in regulatory enforcement create inconsistencies, complicating efforts to standardize practices across the market.
The integration of smart technologies into medical gas systems presents a lucrative opportunity for the Asia Pacific market. Smart systems, equipped with IoT-enabled sensors and real-time monitoring capabilities, allow healthcare providers to track gas usage, detect leaks, and optimize resource allocation. This technological shift aligns with the region’s growing emphasis on digital health transformation. Countries like Japan and South Korea are leading the charge, leveraging their advanced IT infrastructure to implement smart medical gas systems. Also, the rise of telemedicine platforms in the region creates synergies for smart gas systems, enabling remote monitoring of patients receiving oxygen therapy. These advancements not only enhance efficiency but also position manufacturers at the forefront of innovation.
The increasing demand for portable oxygen concentrators represents another significant opportunity for the Asia Pacific medical gas equipment market. These compact devices, which extract oxygen from ambient air, are gaining popularity among patients requiring long-term respiratory support. A large number of people in the Asia Pacific rely on supplemental oxygen therapy, many of whom prefer portable solutions for greater mobility.Emerging economies like India and Indonesia are witnessing a surge in demand due to rising awareness about home healthcare. For example, the segment grew annually between 2020 and 2022, driven by an aging population and a shift toward outpatient care. Portable oxygen concentrators cater to this trend by offering a cost-effective alternative to traditional oxygen cylinders. Manufacturers investing in lightweight, energy-efficient designs stand to benefit from this burgeoning market, particularly as consumer preferences evolve toward convenience and accessibility.
Supply chain disruptions have emerged as a critical challenge for the Asia Pacific medical gas equipment market, exacerbated by geopolitical tensions and logistical bottlenecks. Key components, such as compressors and valves, are often imported from Europe and North America, making the market vulnerable to delays and price fluctuations. Like, lead times for critical equipment increased in recent years, impacting project timelines across the region. Port congestion and container shortages further compound the issue, particularly in major hubs like Singapore and Shanghai. These delays not only inflate costs but also hinder timely installations, affecting healthcare providers’ ability to deliver uninterrupted care. Addressing these vulnerabilities requires diversifying supply chains and investing in local manufacturing capabilities, though these measures come with their own set of challenges.
Another pressing challenge facing the market is the shortage of skilled professionals capable of designing, installing, and maintaining medical gas systems. The complexity of modern systems, particularly those incorporating advanced technologies like IoT and automation, demands specialized expertise. This shortage is particularly acute in rural areas, where healthcare infrastructure is already underdeveloped. The lack of training programs and educational resources further exacerbates the problem, leaving many facilities reliant on external contractors.
The pure medical gases, such as oxygen, nitrogen, and carbon dioxide, dominate the Asia Pacific medical gas equipment market, accounting for approximately 65% of the total share, as per the International Organization for Standardization. The widespread use of pure gases in therapeutic applications, particularly respiratory care, is a key factor driving this segment’s leadership. Oxygen therapy, for instance, is indispensable in managing chronic respiratory conditions like COPD and asthma, which affect a large number of people in the region. One significant driver is the rising prevalence of respiratory disorders, exacerbated by urban air pollution. Cities like Delhi and Beijing consistently rank among the most polluted globally, with particulate matter levels exceeding WHO guidelines by up to five times. This environmental burden has led to a surge in hospital admissions requiring oxygen therapy, creating sustained demand for pure medical gases. Also, government initiatives to improve healthcare infrastructure are amplifying adoption. Another critical factor is the emphasis on patient safety. Pure medical gases are rigorously tested for purity and compliance with ISO standards, making them the preferred choice for critical care units.
The medical gas mixtures, such as nitrous oxide-oxygen blends, is the fastest-growing segment, with a CAGR of 8.7% through 2033. This growth is fueled by their expanding applications in diagnostics and therapeutics. Nitrous oxide-oxygen mixtures, for instance, are widely used in pain management and sedation during minor surgical procedures, a trend gaining traction in outpatient settings. A key driver is the rise in minimally invasive surgeries, which require precise gas mixtures for effective sedation. These procedures often rely on gas mixtures to ensure patient comfort while minimizing recovery times. Another factor is the growing adoption of advanced diagnostic techniques, such as pulmonary function testing, which utilize calibrated gas mixtures. Furthermore, advancements in gas blending technologies have improved accuracy and consistency, enhancing their appeal to healthcare providers.
The flowmeters was the biggest segment in the Asia Pacific medical gas equipment market by holding a 40.8% of the total share. These devices are essential for regulating gas flow rates in therapeutic and diagnostic applications, ensuring precise delivery to patients. One driving factor is the increasing prevalence of respiratory diseases, which necessitate accurate oxygen administration. Another significant driver is the expansion of healthcare facilities, particularly in rural areas. Each hospital will require flowmeters for oxygen delivery systems, creating a steady demand for these devices. Additionally, advancements in digital flowmeter technology, such as IoT integration, are enhancing their functionality.
The Medical air compressors segment is accelerating, with a CAGR of 9.5%. This development is propelled by the increasing demand for medical air in critical care and surgical settings. Medical air is vital for powering ventilators and anesthesia machines, both of which are indispensable in modern healthcare. A key factor is the rise in ICU admissions due to chronic illnesses and infectious diseases. China, for example, witnessed a increase in ICU bed capacity during the pandemic. Each ICU bed requires a reliable supply of medical air, boosting demand for compressors. Another driver is the shift toward home healthcare. Portable medical air compressors are increasingly being adopted for home-based respiratory therapy, further accelerating segment growth.
The therapeutics, particularly respiratory applications, accounted for a 55.5% of the Asia Pacific medical gas equipment market in 2024. This dominance is backed by the high prevalence of respiratory conditions and the critical role of medical gases in their treatment. Chronic respiratory diseases, such as COPD and asthma, affect a substantial number of people in the region. One key driver is urban air pollution, which exacerbates respiratory ailments. The WHO states that air quality in major cities like Jakarta and Manila often exceeds safe limits by up to four times, leading to increased hospitalizations. This trend has amplified the demand for oxygen therapy, a cornerstone of respiratory care. Also, government initiatives to combat non-communicable diseases are fostering adoption. For instance, Thailand’s Universal Coverage Scheme ensures free access to oxygen therapy for low-income patients, enhancing market penetration. Another factor is the aging population, which is more susceptible to respiratory issues.
The diagnostics is the rapidly advancing application segment, with a CAGR of 10.2%. This progress is influenced by the increasing use of medical gases in advanced diagnostic procedures, such as pulmonary function testing and blood gas analysis. A key driver is the rising incidence of chronic lung diseases, which necessitate frequent diagnostic evaluations. Another factor is the adoption of point-of-care testing systems, which utilize medical gases for rapid results. These systems rely on precise gas delivery, creating lucrative opportunities for manufacturers.
By End User Insights
Hospitals became the largest end-user segment by accounting for a 60% of the Asia Pacific medical gas equipment market, as per the International Hospital Federation. This dominance is driven by the concentration of advanced medical facilities in urban centers, which serve as hubs for specialized care. One key driver is the rising number of surgical procedures, which require reliable gas delivery systems. Additionally, government investments in hospital infrastructure are amplifying adoption. Another factor is the emphasis on patient safety. Hospitals prioritize equipment that meets international standards, ensuring consistent performance.
The home healthcare is the fastest-growing end-user segment, with a CAGR of 11.3%. This is caused by the increasing preference for outpatient care and the aging population’s need for long-term respiratory support. A key driver is the affordability of portable gas equipment, such as oxygen concentrators. Another factor is the expansion of telemedicine platforms, which integrate remote monitoring of patients using portable devices.
China held the largest 30 % of the Asia Pacific medical gas equipment market. The country’s dominance stems from its massive healthcare infrastructure and rising prevalence of chronic diseases. A significant portion of Chinese citizens suffer from COPD, creating a robust demand for oxygen therapy systems. Additionally, government initiatives like Healthy China 2030 are driving investments in rural healthcare, ensuring wider adoption of gas equipment.
India commands an impressive portion of the regional market. The country’s position is bolstered by its rapidly expanding hospital network and increasing focus on affordable healthcare. Programs like Ayushman Bharat aim to provide universal health coverage, creating opportunities for medical gas equipment manufacturers.
Japan held a notable position in the market. The country’s aging population and advanced healthcare system drive demand for high-quality gas equipment. Innovations like smart gas systems are gaining traction, aligning with Japan’s emphasis on technological excellence.
South Korea accounts for a key share of the market. The country’s place in robotic surgery and minimally invasive procedures creates a steady demand for precise gas delivery systems, positioning it as a key player in the market.
Australia holds small share of the market. The country’s focus on diagnostic advancements and home healthcare drives adoption. Investments in telehealth and point-of-care testing further enhance market growth.
Air Products and Chemicals, Inc., The Linde Group, Air Liquide, Praxair, Inc., Taiyo Nippon Sanso Corp., SOL-SpA, Airgas, Inc., Atlas Copco, Messer Group, GCE Holding AB, Beacon Medaes, Medical Gas Solutions Ltd., Matheson Tri-Gas, Taiya Nippon Sanso, Atlas Copco, are the major players of Asia-Pacific Medical Gas Equipment Market.
The Asia Pacific medical gas equipment market is characterized by intense competition, driven by the region’s status as a hub for healthcare innovation and infrastructure development. Key players, including multinational corporations and regional manufacturers, vie for dominance by leveraging their technological expertise, extensive service networks, and adaptability to local needs. Multinational firms often emphasize cutting-edge technologies and global standards, while local players focus on cost-effective solutions tailored to regional requirements. The market’s competitive landscape is shaped by collaborations between international companies and domestic healthcare providers, fostering innovation through shared expertise. Additionally, the rise of home healthcare and telemedicine has intensified rivalry, as companies strive to offer versatile and accessible solutions. With increasing demand for efficient and reliable equipment, participants are adopting strategies such as product diversification, strategic partnerships, and enhanced after-sales services to strengthen their foothold.
Linde plc
Linde plc is a global leader in industrial and medical gases, with a significant presence in the Asia Pacific medical gas equipment market. The company’s innovative solutions, such as portable oxygen concentrators and centralized gas delivery systems, cater to diverse healthcare needs across the region. Linde’s commitment to sustainability is evident in its development of energy-efficient systems that align with regional environmental goals. By collaborating with local governments and healthcare providers, Linde has established itself as a trusted partner in improving patient care.
Air Liquide
Air Liquide is a key player in the Asia Pacific market, renowned for its advanced medical gas equipment and comprehensive service offerings. The company’s emphasis on digital transformation has led to the introduction of smart monitoring systems that enhance operational efficiency in hospitals. Air Liquide’s strategic partnerships with regional healthcare institutions have enabled it to expand its footprint while addressing local challenges.
Taiyo Nippon Sanso Corporation
Taiyo Nippon Sanso Corporation is a prominent contributor to the Asia Pacific medical gas equipment market, known for its expertise in gas production and distribution systems. The company’s innovative flowmeters and compressors are widely used in hospitals and diagnostic centers. Taiyo Nippon Sanso’s focus on technological advancements, such as IoT-enabled devices, has positioned it at the forefront of industry innovation.
Innovation-Driven Product Development
Leading players in the Asia Pacific medical gas equipment market prioritize innovation to address emerging healthcare challenges. By developing advanced products like portable oxygen concentrators and smart monitoring systems, companies are meeting the growing demand for efficient and reliable solutions. These innovations not only enhance patient care but also align with global trends toward digitalization and sustainability, ensuring long-term relevance in a competitive market.
Strategic Collaborations and Partnerships
To strengthen their market position, key players are forming alliances with regional healthcare providers, governments, and technology firms. These collaborations facilitate knowledge exchange, improve product customization, and ensure compliance with local standards.
Comprehensive After-Sales Services
Providing end-to-end lifecycle support has emerged as a critical strategy for enhancing customer satisfaction. Companies are investing in training programs, maintenance services, and spare parts distribution networks to ensure uninterrupted operations for healthcare facilities.
This research report on the APAC medical gas equipment market has been segmented and sub-segmented into the following categories.
By Product
By Medical Gas Equipment
By Application
By End-users
By Country
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region